litlas
Log inCreate account

Robert W. Buchanan

Active 1988–2025

Also published as
Robert W Buchanan
136
Papers
23,522
Citations
89
h-index
131
i10-index

Citations

Citations per year for Robert W. Buchanan1982: 1 citations1989: 3 citations1990: 9 citations1991: 10 citations1992: 9 citations1993: 25 citations1994: 31 citations1995: 42 citations1996: 38 citations1997: 92 citations1998: 67 citations1999: 160 citations2000: 148 citations2001: 168 citations2002: 117 citations2003: 156 citations2004: 168 citations2005: 220 citations2006: 202 citations2007: 207 citations2008: 210 citations2009: 288 citations2010: 247 citations2011: 225 citations2012: 231 citations2013: 207 citations2014: 185 citations2015: 195 citations2016: 162 citations2017: 144 citations2018: 137 citations2019: 432 citations2020: 462 citations2021: 401 citations2022: 327 citations2023: 232 citations2024: 389 citations2025: 157 citations2026: 5 citations1983–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,371 citing papers, 30.9% of this breakdownUnited Kingdom: 741 citing papers, 9.6% of this breakdownGermany: 480 citing papers, 6.2% of this breakdownCanada: 432 citing papers, 5.6% of this breakdownChina: 325 citing papers, 4.2% of this breakdownAustralia: 317 citing papers, 4.1% of this breakdownItaly: 317 citing papers, 4.1% of this breakdownSpain: 263 citing papers, 3.4% of this breakdownNetherlands: 242 citing papers, 3.2% of this breakdownSwitzerland: 200 citing papers, 2.6% of this breakdownJapan: 173 citing papers, 2.3% of this breakdownFrance: 167 citing papers, 2.2% of this breakdown
0%30.9%Other 21.6%

Institutions

Fields

  • Medicine57.4%
  • Neuroscience25.2%
  • Biochemistry, Genetics and Molecular Biology8.3%
  • Psychology5.9%
  • Computer Science0.8%
  • Health Professions0.6%
  • Other1.8%

Topics

  • Schizophrenia research and treatment19.4%
  • Functional Brain Connectivity Studies5.9%
  • Mental Health and Psychiatry4.5%
  • Tryptophan and brain disorders4.5%
  • Bipolar Disorder and Treatment3.1%
  • Advanced Neuroimaging Techniques and Applications3%
  • Other59.6%

Coauthors

All papers

Open in search
  1. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

    Authors: Oliver Howes, Robert A. McCutcheon, Ofer Agid, Andrea de Bartolomeis, Nico J.M. van Beveren, Michael L. Birnbaum, Michael Bloomfield, Rodrigo A. Bressan, Robert W. Buchanan, William T. Carpenter, David Castle, Leslie Citrome, Zafiris J. Daskalakis, Michael Davidson, Richard Drake, Serdar Dursun, Bjørn H. Ebdrup, Hélio Elkis, Peter Falkai, W. Wolfgang Fleischacker, Ary Gadelha, Fiona Gaughran, Birte Glenthøj, Ariel Graff‐Guerrero, Jorge Hallak, William G. Honer, James L. Kennedy, Bruce J. Kinon, Stephen M. Lawrie, Jimmy Lee, F. Markus Leweke, James H. MacCabe, Carolyn McNabb, Herbert Y. Meltzer, Hans‐Jürgen Möller, Shinchiro Nakajima, Christos Pantelis, Tiago Reis Marques, Gary Remington, Susan L. Rossell, Bruce R. Russell, Cynthia Siu, Takefumi Suzuki, Iris E. Sommer, David Taylor, Neil Thomas, Alp Üçok, Daniel Umbricht, James Walters, John M. Kane, Christoph U. Correll - American Journal of Psychiatry 2016 cited by 1,106

  2. Negative symptoms of schizophrenia: new developments and unanswered research questions

    Authors: Silvana Galderisi, Armida Mucci, Robert W. Buchanan, Celso Arango - The Lancet Psychiatry 2018 cited by 550

  3. White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study

    Authors: Suheyla Cetin‐Karayumak, Maria A. Di Biase, Natalia Chunga, Benjamin Reid, Nathaniel Somes, Amanda E. Lyall, Sinéad Kelly, Bengisu Solgun, Ofer Pasternak, Márk Vangel, Godfrey D. Pearlson, Carol A. Tamminga, John A. Sweeney, Brett A. Clementz, David J. Schretlen, Petra Viher, Katharina Stegmayer, Sebastian Walther, Jung Sun Lee, Tim Crow, Anthony James, Aristotle N. Voineskos, Robert W. Buchanan, Philip R. Szeszko, Anil K. Malhotra, Rachal Hegde, Robert W. McCarley, Matcheri S. Keshavan, Martha E. Shenton, Yogesh Rathi, Marek Kubicki - Molecular Psychiatry 2019 cited by 187

  4. Deconstructing negative symptoms of schizophrenia: Avolition–apathy and diminished expression clusters predict clinical presentation and functional outcome

    Authors: Gregory P. Strauss, William P. Horan, Brian Kirkpatrick, Bernard A. Fischer, William R. Keller, Pinar Miski, Robert W. Buchanan, Michael F. Green, William T. Carpenter - Journal of Psychiatric Research 2013 cited by 438

  5. Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions

    Authors: Aristotle N. Voineskos, Colin Hawco, Nicholas H. Neufeld, Jessica A. Turner, Stephanie H. Ameis, Alan Anticevic, Robert W. Buchanan, Kristin S. Cadenhead, Paola Dazzan, Erin W. Dickie, Julia Gallucci, Adrienne C. Lahti, Anil K. Malhotra, Döst Öngür, Todd Lencz, Deepak K. Sarpal, Lindsay D. Oliver - World Psychiatry 2024 cited by 66

  6. Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group

    Authors: Elias Wagner, Dan Siskind, Peter Falkai, Oliver Howes, Christoph U. Correll, Jimmy Lee, William G. Honer, John M. Kane, Emilio Fernández-Egea, Thomas R. E. Barnes, Alkomiet Hasan, TRRIP Working Group, Ofer Agid, Celso Arango, Lone Baandrup, Thomas R. E. Barnes, Andrea de Bartolomeis, Nico J.M. van Beveren, Michael L. Birnbaum, István Bitter, Alain Breier, Robert W. Buchanan, William T. Carpenter, David Castle, Eric Chen, Leslie Citrome, David Cotter, Christoph U. Correll, Benedicto Crespo‐Facorro, Michael Davidson, Richard Drake, Sonia Dollfus, Serdar Dursun, Bjørn H. Ebdrup, Robin Emsley, Emilio Fernández-Egea, Hélio Elkis, Peter Falkai, Wolfgang Fleischhacker, Oliver Freudenreich, Ary Gadelha, Wolfgang Gäebel, Birte Glenthøj, Donald Goff, Ariel Graff‐Guerrero, Jorge Hallak, Alkomiet Hasan, William G. Honer, Philip Homan, Oliver Howes, René S. Kahn, Stefan Kaiser, John M. Kane, James L. Kennedy, Bruce J. Kinon, Euitae Kim, Stephen M. Lawrie, Jimmy Lee, Stefan Leucht, F. Markus Leweke, Jan Libiger, Antony Loebel, James H. MacCabe, Stephen R. Marder, Robert A. McCutcheon, Ingrid Melle, Herbert Y. Meltzer, Armida Mucci, Dieter Naber, Shinchiro Nakajima, Jimmi Nielsen, Oisín O’Brien, Akin Ojagbemi, Christos Pantelis, Joseph Peuskens, Steven G. Potkin, Tiago Reis Marques, Thomas J. Raedler, Gary Remington, Susan L. Rossell, Jose Rubio-Lorente, Gabriele Sachs, Dan Siskind, Cynthia Siu, Iris E. Sommer, Jun Soo Kwon, Takefumi Suzuki, Jaana Suvisaari, Hiroyoshi Takeuchi, Rajiv Tandon, David Taylor, Neil Thomas, Jari Tiihonen, Hiroyuki Uchida, Alp Üçok, Daniel Umbricht, Ganesan Venkatasubramanian, Elias Wagner, James Walters, Chuanyue Wang and 2 more - Schizophrenia Bulletin 2023 cited by 38

  7. Improving the predictive potential of diffusion MRI in schizophrenia using normative models—Towards subject‐level classification

    Authors: Doron Elad, Suheyla Cetin‐Karayumak, Fan Zhang, Kang Ik K. Cho, Amanda E. Lyall, Johanna Seitz‐Holland, Rami Ben‐Ari, Godfrey D. Pearlson, Carol A. Tamminga, John A. Sweeney, Brett A. Clementz, David J. Schretlen, Petra Viher, Katharina Stegmayer, Sebastian Walther, Jung Sun Lee, Tim Crow, Anthony James, Aristotle N. Voineskos, Robert W. Buchanan, Philip R. Szeszko, Anil K. Malhotra, Matcheri S. Keshavan, Martha E. Shenton, Yogesh Rathi, Sylvain Bouix, Nir Sochen, Marek Kubicki, Ofer Pasternak - Human Brain Mapping 2021 cited by 37

  8. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms

    Authors: L. Felice Reddy, William P. Horan, Deanna M. Barch, Robert W. Buchanan, Eduardo Dunayevich, James M. Gold, Naomi Lyons, Stephen R. Marder, Michael T. Treadway, Jonathan K. Wynn, Jared W. Young, Michael F. Green - Schizophrenia Bulletin 2015 cited by 173

  9. The schedule for the deficit syndrome: An instrument for research in schizophrenia

    Authors: Brian Kirkpatrick, Robert W. Buchanan, Patricia D. McKenny, Larry Alphs, William T. Carpenter - Psychiatry Research 1989 cited by 815

  10. The neurological evaluation scale (NES): A structured instrument for the assessment of neurological signs in schizophrenia

    Authors: Robert W. Buchanan, Douglas W Heinrichs - Psychiatry Research 1989 cited by 588

  11. Schizophrenia

    Authors: William T. Carpenter, Robert W. Buchanan - New England Journal of Medicine 1994 cited by 516

  12. Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow

    Authors: Stephanie Hare, Bhim M. Adhikari, Mo Chen, Shuo Chen, S. Andrea Wijtenburg, Chamindi Seneviratne, Samuel Kane-Gerard, Korrapati V. Sathyasaikumar, Francesca M. Notarangelo, Robert Schwarcz, Deanna L. Kelly, Laura M. Rowland, Robert W. Buchanan - Neuropsychopharmacology 2023 cited by 21

  13. Characterization of the extracellular free water signal in schizophrenia using multi-site diffusion MRI harmonization

    Authors: Suheyla Cetin‐Karayumak, Amanda E. Lyall, Maria A. Di Biase, Johanna Seitz‐Holland, Fan Zhang, Sinéad Kelly, Doron Elad, Godfrey D. Pearlson, Carol A. Tamminga, John A. Sweeney, Brett A. Clementz, David J. Schretlen, Katharina Stegmayer, Sebastian Walther, Jung Sun Lee, Tim Crow, Anthony James, Aristotle N. Voineskos, Robert W. Buchanan, Philip R. Szeszko, Anil K. Malhotra, Matcheri S. Keshavan, Martha E. Shenton, Yogesh Rathi, Ofer Pasternak, Marek Kubicki - Molecular Psychiatry 2023 cited by 21

  14. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments

    Authors: Robert W. Buchanan, Daniel C. Javitt, Stephen R. Marder, Nina R. Schooler, James M. Gold, Robert P. McMahon, Uriel Heresco‐Levy, William T. Carpenter - American Journal of Psychiatry 2007 cited by 420

  15. Separable and Replicable Neural Strategies During Social Brain Function in People With and Without Severe Mental Illness

    Authors: Colin Hawco, Robert W. Buchanan, Navona Calarco, Benoit H. Mulsant, Joseph D. Viviano, Erin W. Dickie, Miklós Árgyelán, James M. Gold, Marco Iacoboni, Pamela DeRosse, George Foussias, Anil K. Malhotra, Aristotle N. Voineskos, for the SPINS Group - American Journal of Psychiatry 2019 cited by 50

  16. Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis

    Authors: Spyridon Siafis, Lasse Brandt, Robert A. McCutcheon, Stefan Gutwinski, Johannes Schneider‐Thoma, Irene Bighelli, John M. Kane, Celso Arango, René S. Kahn, W. Wolfgang Fleischhacker, Patrick D. McGorry, William T. Carpenter, Peter Falkai, Alkomiet Hasan, Stephen R. Marder, Nina R. Schooler, Rolf R. Engel, William G. Honer, Robert W. Buchanan, Michael Davidson, Mark Weiser, Josef Priller, John M. Davis, Oliver Howes, Christoph U. Correll, Stefan Leucht - The Lancet Psychiatry 2023 cited by 24

  17. Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial

    Authors: Deanna L. Kelly, Matthew Glassman, Ikwunga Wonodi, Gopal Vyas, Charles M. Richardson, Evaristus Nwulia, Heidi J. Wehring, Taiwo Oduguwa, Marie Mackowick, Maria Hipolito, Olawunmi Peters, Narayan Rai, Jaeboon Park, Adeola Adebayo, David A. Gorelick, Elaine Weiner, Fang Liu, Ann Marie Kearns, Heather A. Adams, Raymond C. Love, Shuo Chen, Ayodeji Olaniyan, Nicholas P. Ambulos, Darius McKoy, Madhulika C. Nallani, Sophie Lanzkron, Mulu Mengistab, Brian Barr, Erica Davis, Rahman Lawal, Robert W. Buchanan, Richard A. Adebayo - Schizophrenia Research 2023 cited by 22

  18. A Separate Disease Within the Syndrome of Schizophrenia

    Authors: Brian Kirkpatrick, Robert W. Buchanan, David E. Ross, William T. Carpenter - Archives of General Psychiatry 2001 cited by 653

  19. Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine

    Authors: L. Elliot Hong, Ann Summerfelt, Robert W. Buchanan, Patricio O’Donnell, Gunvant K. Thaker, Martin A. Weiler, Adrienne C. Lahti - Neuropsychopharmacology 2009 cited by 283

  20. Social Cognitive Networks and Social Cognitive Performance Across Individuals With Schizophrenia Spectrum Disorders and Healthy Control Participants

    Authors: Lindsay D. Oliver, Colin Hawco, Philipp Homan, Junghee Lee, Michael F. Green, James M. Gold, Pamela DeRosse, Miklós Árgyelán, Anil K. Malhotra, Robert W. Buchanan, Aristotle N. Voineskos - Biological Psychiatry Cognitive Neuroscience and Neuroimaging 2020 cited by 36

  21. The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009

    Authors: Julie Kreyenbuhl, Robert W. Buchanan, Faith Dickerson, Lisa B. Dixon - Schizophrenia Bulletin 2009 cited by 500

  22. Persistent Negative Symptoms in Schizophrenia: An Overview

    Authors: Robert W. Buchanan - Schizophrenia Bulletin 2006 cited by 441

  23. Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia

    Authors: Nicole R. Giuliani, Vince D. Calhoun, Godfrey D. Pearlson, Alan Francis, Robert W. Buchanan - Schizophrenia Research 2004 cited by 268

  24. Factor structure of the brief negative symptom scale

    Authors: Gregory P. Strauss, L. Elliot Hong, James M. Gold, Robert W. Buchanan, Robert P. McMahon, William R. Keller, Bernard A. Fischer, Lauren T. Catalano, Adam J. Culbreth, William T. Carpenter, Brian Kirkpatrick - Schizophrenia Research 2012 cited by 195